Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity
Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim
Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases
GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November
Nosopharm appoints Dr Sarah Gould as chief development officer
Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes
Bionure appoints Dr. Laurent Nguyen as CEO
Minoryx Therapeutics raises €21.3M in Series B funding round
